Zhu ZL - Search Results

1

Pharmacokinetics of panaxatrol disuccinate sodium, a novel anti-cancer drug from Panax notoginseng, in healthy volunteers and patients with advanced solid tumors.

Yan Z, Zhu ZL, Wang HQ, Li W, Mi YX, Liu CX. Yan Z, et al. Among authors: zhu zl. Acta Pharmacol Sin. 2010 Nov;31(11):1515-22. doi: 10.1038/aps.2010.114. Acta Pharmacol Sin. 2010. PMID: 21052087 Free PMC article. Clinical Trial.

2

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.

Yan Z, Zhu Z, Li K, Chen P, Wang L, Huang C, Xue J, Liu M. Yan Z, et al. Cancer Chemother Pharmacol. 2011 Apr;67(4):955-61. doi: 10.1007/s00280-010-1546-z. Epub 2010 Dec 30. Cancer Chemother Pharmacol. 2011. PMID: 21191594 Clinical Trial.

3

Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors.

Yan Z, Zhu ZL, Qian ZZ, Hu G, Wang HQ, Liu WH, Cheng G. Yan Z, et al. Among authors: zhu zl. Acta Pharmacol Sin. 2012 Jun;33(6):852-8. doi: 10.1038/aps.2012.44. Acta Pharmacol Sin. 2012. PMID: 22669119 Free PMC article. Clinical Trial.

4

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors.

Zhu Z, Qian Z, Yan Z, Zhao C, Wang H, Ying G. Zhu Z, et al. Int J Nanomedicine. 2013;8:129-36. doi: 10.2147/IJN.S38271. Epub 2013 Jan 4. Int J Nanomedicine. 2013. PMID: 23319864 Free PMC article. Clinical Trial.

5

Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway.

Yan Z, Zhu Z, Wang J, Sun J, Chen Y, Yang G, Chen W, Deng Y. Yan Z, et al. Mol Cancer. 2013 Oct 7;12(1):116. doi: 10.1186/1476-4598-12-116. Mol Cancer. 2013. PMID: 24098916 Free PMC article.

6

Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression.

Zhu Z, Du S, Ding F, Guo S, Ying G, Yan Z. Zhu Z, et al. Am J Transl Res. 2016 Jul 15;8(7):3299-308. eCollection 2016. Am J Transl Res. 2016. PMID: 27508051 Free PMC article.

7

BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus.

Ding F, Wang M, Du Y, Du S, Zhu Z, Yan Z. Ding F, et al. Sci Rep. 2016 Dec 2;6:38331. doi: 10.1038/srep38331. Sci Rep. 2016. PMID: 27910912 Free PMC article.

8

BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling.

Bao H, Zhang Q, Zhu Z, Xu H, Ding F, Wang M, Du S, Du Y, Yan Z. Bao H, et al. Sci Rep. 2017 Aug 22;7(1):9153. doi: 10.1038/s41598-017-09655-7. Sci Rep. 2017. PMID: 28831201 Free PMC article.

9

Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis.

Zhu Z, Du S, Du Y, Ren J, Ying G, Yan Z. Zhu Z, et al. J Neurochem. 2018 Jan;144(1):93-104. doi: 10.1111/jnc.14250. Epub 2017 Dec 5. J Neurochem. 2018. PMID: 29105080 Free article.

10

Apoptosis induction in K562 human myelogenous leukaemia cells is connected to the modulation of Wnt/β-catenin signalling by BHX, a novel pyrazoline derivative.

Bao H, Zhang Q, Du Y, Zhang C, Xu H, Zhu Z, Yan Z. Bao H, et al. Cell Prolif. 2018 Jun;51(3):e12433. doi: 10.1111/cpr.12433. Epub 2018 Jan 16. Cell Prolif. 2018. PMID: 29341317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters